Lilly loses to Emisphere

In January, 2006, federal judge David F. Hamilton ruled after a trial that Lilly breached its contract with Emisphere by setting up a secret research team to study its partner's technology on the sly. In a decision released April 26, the judge ruled Lilly should hand over the international patent application [PCT] to Emisphere Technologies by May 5, 2006. The technology relates to an injectible bone-strengthening drug.